NFL Biosciences SA (82F) Financial Statements

1 Followers

NFL Biosciences SA Financial Overview

NFL Biosciences SA's market cap is currently €11.35M. The company's EPS TTM is €-0.12; its P/E ratio is -3.54; NFL Biosciences SA is scheduled to report earnings on April 15, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	€ 0.00	€ 46.00	€ 200.01K	€ 0.00	€ 39.00
Gross Profit	€ -2.52M	€ -67.14K	€ -56.06K	€ -2.24M	€ -530.73K
Operating Income	€ -3.87M	€ -2.79M	€ -4.43M	€ -3.01M	€ -901.87K
EBITDA	€ -3.79M	€ -2.65M	€ -4.05M	€ -2.81M	€ -1.08M
Net Income	€ -3.32M	€ -2.08M	€ -3.75M	€ -2.44M	€ -978.24K
Balance Sheet
Cash & Short-Term Investments	€ 2.20M	€ 2.11M	€ 2.53M	€ 1.21M	€ 3.20M
Total Assets	€ 3.66M	€ 3.61M	€ 3.97M	€ 2.40M	€ 3.69M
Total Debt	€ 582.59K	€ 40.98K	€ 62.17K	€ 83.26K	€ 85.01K
Net Debt	€ -1.42M	€ -1.87M	€ -2.28M	€ -970.33K	€ -2.95M
Total Liabilities	€ 3.36M	€ 2.63M	€ 3.62M	€ 1.55M	€ 397.73K
Stockholders' Equity	€ 306.14K	€ 976.43K	€ 349.94K	€ 844.00K	€ 3.29M
Cash Flow
Free Cash Flow	€ 0.00	€ 0.00	€ 0.00	€ 104.89K	€ 87.00K
Operating Cash Flow	€ 0.00	€ 0.00	€ 0.00	€ 104.89K	€ 87.00K
Investing Cash Flow	€ 0.00	€ 0.00	€ 0.00	€ 0.00	€ 0.00
Financing Cash Flow	€ 0.00	€ 0.00	€ 0.00	€ 0.00	€ 0.00

Currency in EUR

NFL Biosciences SA Earnings and Revenue History

Income Statement >

NFL Biosciences SA Debt to Assets

Balance Sheet >

NFL Biosciences SA Cash Flow

Cash Flow >

NFL Biosciences SA Forecast EPS vs Actual EPS

Earnings >